European Cannabis Market Leader Bloomwell Group Secures $10M Investment
Summary
• Investment ushers in new era of “natural based medicine“ • Showcases Germany as the leading European market for medical cannabis FRANKFURT, Germany, Oct. 18, 2021 – PRESS RELEASE – Bloomwell Group has successfully closed a seed funding round of over $10 million dollars—the highest publicly known seed investment for a European cannabis company to date. The lead investor is U.S. growth capital provider Measure 8 Venture Partners, specialists in cannabis industry investments. The accomplished board covers facets in medicine, digitalization, cannabis, investment and brand building across various market sectors. • Dr. Reinhard Meier, Director of Radiology at Westpfalz Klinikum, previously founded and invested in several medical companies as well as initiating several VC funds. While the market is consolidating elsewhere, all signs point towards growth and expansion through the combination of cannabis, innovation, digitalization and a radical D2C or direct-to-patient approach."